169 related articles for article (PubMed ID: 25337264)
1. High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
Sun Q; Zhao C; Xia L; He Z; Lu Z; Liu C; Jia M; Wang J; Niu J
Int J Clin Exp Pathol; 2014; 7(9):6157-64. PubMed ID: 25337264
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
Sun Q; Li F; Sun F; Niu J
Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K
Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Matrix Metalloproteinase-11 indicates Poor Prognosis in Human Cholangiocarcinoma.
Tongtawee T; Kaewpitoon SJ; Loyd R; Chanvitan S; Leelawat K; Praditpol N; Jujinda S; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(9):3697-701. PubMed ID: 25987024
[TBL] [Abstract][Full Text] [Related]
5. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
Zhang C; Tu Z; Du S; Wang Y; Wang Q
Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
[TBL] [Abstract][Full Text] [Related]
7. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
8. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
9. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
Huang YC; Chen M; Shyr YM; Su CH; Chen CK; Li AF; Ho DM; Chen YM
J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of neutrophil distribution in cholangiocarcinoma.
Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
[TBL] [Abstract][Full Text] [Related]
12. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
13. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
14. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
[TBL] [Abstract][Full Text] [Related]
15. CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Shimada M
Anticancer Res; 2017 Oct; 37(10):5701-5705. PubMed ID: 28982889
[TBL] [Abstract][Full Text] [Related]
16. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of C-met Expression in Cholangiocarcinoma.
Mao ZY; Zhu GQ; Ren L; Guo XC; Su D; Bai L
Technol Cancer Res Treat; 2016 Apr; 15(2):227-33. PubMed ID: 25873560
[TBL] [Abstract][Full Text] [Related]
18. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
[TBL] [Abstract][Full Text] [Related]
19. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]